Theriva Biologics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Theriva Biologics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Theriva Biologics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 22.4M shares, a 31.4% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 22.4M +5.35M +31.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 17.1M +2.02M +13.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 17.1M +2.02M +13.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 17M +1.2M +7.57% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 17M +1.2M +7.56% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 15.1M -143M -90.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 15.1M +1.92M +14.5% Dec 31, 2022 10-K 2024-03-25
Q3 2022 15.8M -116M -88% Sep 30, 2022 10-K 2023-03-30
Q2 2022 15.8M -116M -88% Jun 30, 2022 10-K 2023-03-30
Q1 2022 158M +26.4M +20% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 13.2M -16M -54.9% Dec 31, 2021 10-K 2023-03-30
Q3 2021 132M +112M +565% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 132M +113M +608% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 132M +114M +644% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 29.2M +12.4M +74% Dec 31, 2020 10-K 2022-03-16
Q3 2020 19.8M +3.04M +18.1% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 18.6M +2M +12% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 17.7M +1.36M +8.28% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 16.8M +1.32M +8.55% Dec 31, 2019 10-K 2021-03-04
Q3 2019 16.8M +11.5M +214% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 16.6M -114M -87.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 16.4M -112M -87.3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 15.5M +11.8M +322% Dec 31, 2018 10-K 2020-02-20
Q3 2018 5.34M -123M -95.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 130M +2.55M +2% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 129M +10.6M +9.01% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 3.67M -114M -96.9% Dec 31, 2017 10-K 2019-02-27
Q3 2017 129M +36.9M +40.3% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 128M +36.5M +40% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 118M +27.1M +29.8% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 117M +26.3M +29% Dec 31, 2016 10-K 2018-02-22
Q3 2016 91.7M +842K +0.93% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 91.3M +18.1M +24.7% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 90.8M +18M +24.7% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 90.8M +18.3M +25.3% Dec 31, 2015 10-K 2017-03-02
Q3 2015 90.8M +32.4M +55.4% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 73.2M +14.7M +25.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 72.8M +14.4M +24.6% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 72.5M +14.3M +24.6% Dec 31, 2014 10-K 2016-03-10
Q3 2014 58.5M +13.8M +30.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 58.5M +13.8M +30.9% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 58.4M +13.8M +30.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 58.2M +13.9M +31.2% Dec 31, 2013 10-K 2015-03-16
Q3 2013 44.7M +11.3M +33.7% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 44.7M +11.4M +34.1% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 44.7M +11.9M +36.2% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 44.4M +13.1M +41.8% Dec 31, 2012 10-K 2014-03-31
Q3 2012 33.4M +5.19M +18.4% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 33.3M +5.3M +18.9% Jun 30, 2012 10-Q/A 2012-09-11
Q1 2012 32.8M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 31.3M +7.95M +34.1% Dec 31, 2011 10-K 2013-04-16
Q3 2011 28.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 28M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 23.3M Dec 31, 2010 10-K/A 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.